Metastatic differentiated thyroid carcinoma: Clinicopathological profile and outcome in an iodine deficient area

被引:0
|
作者
Mishra, A
Mishra, SK
Agarwal, A
Das, BK
Agarwal, G
Gambhir, S
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrine Surg, Lucknow 226014, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Nucl Med, Lucknow 226014, Uttar Pradesh, India
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Reports on metastatic differentiated carcinoma in endemic goiter regions are scarce. The aim of this study was to look into the clinicopathological profile and outcome of patients with metastatic differentiated thyroid carcinoma (DTC) of endemic origin. This was a retrospective study of 28 cases of metastatic DTC out of a total of 140 DTC patients managed between 1990 and June 1999. Demographic data, clinicopathological profile, operative and radioiodine ablation therapy details, and follow-up findings were noted. The overall incidence of distant metastases in our series was 20%. Mean age was 48.5 +/- 12.8 years (32.1% patients were < 45 years). Most metastases were detected synchronously (85.7%) and were multiple, with the skeletal system being the commonly affected site. Out of 22 cases having skeletal metastases, 6 patients were young (< 45 years). Though most patients with skeletal metastases had follicular carcinoma (FTC), 4 cases had papillary thyroid cancer (PTC). Near total or total thyroidectomy was done in 26 cases. Sixteen patients required regional lymph node dissection. Resection of metastases was performed in 9 cases. Histopathological diagnosis was PTC, FTC, and poorly differentiated carcinoma in 32.1%, 50.0%, and 17.9% of cases, respectively. Most patients had good symptomatic palliation following administration of I-131 therapy. In 17.9% of cases there were locoregional recurrences. There was an overall 28.6% mortality. Two patients expired in the perioperative period. Six others died in follow-up (all within 3-9 months). In contrast to iodine sufficient regions, the incidence of metastases was high; the majority of cases had synchronous, symptomatic skeletal metastases. Skeletal metastases were not infrequent even in cases of PTC and in young patients. One-third of the cases were young. Though survival was poor despite aggressive management, significant symptomatic palliation could be achieved in most cases.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [21] Survival in patients with metastatic differentiated thyroid carcinoma
    Biermann, K.
    Raddatz, J.
    Ezziddin, S.
    Bucerius, J.
    Brockmann, H.
    Ahmadzadehfar, H.
    Palmedo, H.
    Biersack, H. -J.
    ONKOLOGIE, 2008, 31 : 114 - 114
  • [22] Radioactive iodine treatment for differentiated thyroid carcinoma in Japan
    Okamoto, Takahiro
    SURGERY, 2010, 147 (03) : 432 - 433
  • [23] Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer
    Verburg, Frederik A.
    Haenscheid, Heribert
    Luster, Markus
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 279 - 290
  • [24] Update on iodine-refractory differentiated thyroid carcinoma
    Casas, E. Abou Jokh
    Repetto, A.
    Gasen, A. Rodriguez
    Conejero, J. L. Vercher
    Arques, P. Bello
    Molina, T. Cambil
    Casas, J. A. Vallejo
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 324 - 333
  • [25] Phase II trial of regorafenib in metastatic medullary thyroid carcinoma (MTC) and radioactive iodine refractory differentiated thyroid carcinoma (RAIR DTC)
    Sehgal, Kartik
    Shi, Ruichao
    Pappa, Theodora
    Min, Judy K.
    Oakley, Liam B.
    ONeill, Anne
    Dennis, Michael J.
    Deshpande, Hari Anant
    Haddad, Robert I.
    Lorch, Jochen H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Outcome of patients with differentiated thyroid carcinoma and nodal metastases, treated initially by surgery and by radioactive iodine
    Stefanovic, L.
    Mihailovic, J.
    Malesevic, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S223 - S223
  • [27] Pathology and molecular profile of differentiated thyroid carcinoma
    Theurer, S.
    Rawitzer, J.
    Schmid, K. W.
    CHIRURG, 2020, 91 (12): : 999 - 1006
  • [28] TREATMENT OF METASTATIC CARCINOMA OF THYROID WITH RADIOACTIVE IODINE
    DUGGAN, HE
    WEIJER, DL
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1961, 84 (23) : 1318 - &
  • [29] TREATMENT OF METASTATIC THYROID CARCINOMA WITH RADIOACTIVE IODINE
    不详
    BRITISH MEDICAL JOURNAL, 1951, 1 (4709): : 748 - 748
  • [30] Thyroid disorders in a former iodine-deficient area
    Völzke, H
    Lüdemann, J
    Robinson, D
    Kramer, A
    Meng, W
    John, U
    GESUNDHEITSWESEN, 2003, 65 (8-9) : A32 - A32